FDA.report

Application 076067

Type
ANDA
Sponsor
PERRIGO NEW YORK

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001MOMETASONE FUROATEMOMETASONE FUROATEOINTMENT;TOPICAL0.1%NoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-119Mometasone FuroateMometasone FuroatePerrigo New York IncANDACurrent
45802-119Mometasone FuroateMometasone FuroatePerrigo New York IncANDACurrent
45802-119Mometasone FuroateMometasone FuroatePadagis Israel Pharmaceuticals LtdANDACurrent
50090-1633Mometasone FuroateMometasone FuroateA-S Medication SolutionsANDACurrent
63629-8683Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-8683Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-8683Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-8684Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-8684Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-8684Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-9305Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
63629-9306Mometasone FuroateMometasone FuroateBryant Ranch PrepackANDACurrent
70518-3244Mometasone FuroateMometasone FuroateREMEDYREPACK INC.ANDACurrent
70518-3244Mometasone FuroateMometasone FuroateREMEDYREPACK INC.ANDACurrent
71205-413Mometasone FuroateMometasone FuroateProficient Rx LPANDACurrent

Documents

DocumentSubmission typeDate
43047ORIG2003-12-24
39502ORIG2003-12-24
8860ORIG2003-04-10
8859ORIG2003-04-10